Identification of a polymorphism in the transmembrane domain of the protooncogene c-kit in healthy subjects

Experimental and Clinical Immunogenetics

Volumn 13, Issue 3-4, 1997, Pages 210-214

  Nagata, Hiroshi ^a   Worobec, Alexandra S ^a   Metcalfe, Dean D ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

c kit; Mastocytosis; Protein tyrosine kinase; Stem cell factor

Indexed keywords

DNA; LEUCINE; METHIONINE; STEM CELL FACTOR RECEPTOR;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GERM CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAST CELL; MELANOCYTE; NORMAL HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTO ONCOGENE;

ADULT; ALLELES; EXONS; FAMILY HEALTH; FEMALE; GENE FREQUENCY; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LEUCINE; MALE; MEMBRANE PROTEINS; METHIONINE; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 12644254740     PISSN: 02549670     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Morrison-Graham K, Takahashi Y: Steel factor and c-kit receptor: From mutants to a growth factor system. Bioessays 1993;15:77-83.
2. Fleischman RA. From white spots to stem cells: The role of the kit receptor in mammalian development. Trends Genet 1993;9:285-290.
3. Kitamura Y, Tsujimura T, Jippo T, Kasugai T, Kanakura Y: Development of mast cells and basophils: Role of c-kit receptor tyrosine kinase for development, survival and neoplastic transformation of mast cells; in Kitamura Y, Yamamoto S, Galli S, Greaves MW (eds): Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function. New York, Raven Press, 1995, pp 91-103.
4. Spritz RA: Molecular basis of human piebaldism. J Invest Dermatol 1994;103(suppl):137S-140S.
5. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD: Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 1995;92:10560-10564.
6. Longley BJ, Tyrrell L, Lu S, Ma Y, Langley K, Ding T, Duffy T, Jacobs P, Tang LH, Modlin I: Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nat Genet 1996;12:312-314.
7. Metcalfe DD: Classification and diagnosis of mastocytosis: Current status. J Invest Dermatol 1991; 96(suppl):2S-4S.
8. Yarden Y, Kuang WJ, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, Chen E, Schlessinger J, Francke U, Ullrich A: Human proto-oncogene c-kit: A new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987;6:3341-3351.
9. Giebel LB, Strunk KM, Holmes SA, Spritz RA: Organization and nucleotide sequence of the human KIT (mast/stem cell growth factor receptor) proto-oncogene. Oncogene 1992;7:2207-2217.
10. Smith CIE, Vihinen M: Immunodeficiency mutation databases - A new research tool. Immunol Today 1996; 17:485-496.
11. Buckley RH, Schiff SE, Schiff RI: Human severe combined immunodeficiency (SCID): Genetic, phenotypic and functional diversity in 108 infants. J Pediatr, in press.
12. Puck JM: IL2RG base: A database of γc-chain defects causing human X-SCID. Immunol Today 1996;17: 507-510.
13. Notarangelo LD, Peitsch M: CD40Lbase: A database of CD40L gene mutations causing X-linked hyper-IgM syndrome. Immunol Today 1996;17:511-516.
14. Vihinen M: BTKbase: XLA-mutation registry. Immunol Today 1996; 17:502-506.
15. Yel L, Minegishi Y, Coustan-Smith E, Buckley R, Trubel H, Pochman L, Kitchingman G: Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 1996;335:1486-1493.
16. Schwarz K: WASPbase: A database of WAS- and XLT-causing mutations. Immunol Today 1996; 17: 496-502.
17. Elder M, Lin D, Clever J, Chan A, Hope T, Weiss A, Parslow T: Human severe combined immunodeficiency due to a defect in ZAP70, a T cell tyrosine kinase. Science 1994; 264:1596-1599.
18. Wange RL, Guitian R, Isakov N, Watts JD, Aebersold R, Samelson LE. Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J Biol Chem 1995;270:18730-18733.
19. Drumm ML, Collins FS: Molecular biology of cystic fibrosis. Mol Genet Med 1993;3:33-68.
20. Harris A, Argent BE: The cystic fibrosis gene and its product CFTR. Semin Cell Biol 1993;4:37-44.
21. Dean M, Santis G: Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutations. Hum Genet 1994;93:364-368.
22. Qiu F, Ray P, Brown K, Baker PE, Jhanwar S, Ruddle FH, Besmer P: Primary structure of c-kit: Relationship with the CSF-1/PDGF receptor kinase family - Oncogenic activation of v-kit involves deletion of extracellular domain and C terminus. EMBO J 1988,7:1003-1011.